| Literature DB >> 19672897 |
Britta Siegmund1, Martin Zeitz.
Abstract
Inflammatory bowel disease (IBD) accompanies its patients throughout life. Current treatment options do not lead to a cure and are accompanied by significant toxicities. Numerous animal models contributed to the understanding of the pathogenesis of the disease and led to the development of novel treatment strategies. Genome-wide association analysis added a novel dimension. Here, we discuss how characterization of mutated genes in animal models supports the identification of future therapeutic targets.Entities:
Mesh:
Substances:
Year: 2009 PMID: 19672897 DOI: 10.1002/eji.200939601
Source DB: PubMed Journal: Eur J Immunol ISSN: 0014-2980 Impact factor: 5.532